Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Oral administration of viable Bifidobacterium pseudolongum strain Patronus modified colonic microbiota and increased mucus layer thickness in rat.

Mangin I, Dossou-Yovo F, Lévêque C, Dessoy MV, Sawoo O, Suau A, Pochart P.

FEMS Microbiol Ecol. 2018 Nov 1;94(11). doi: 10.1093/femsec/fiy177.

PMID:
30184128
2.

Structural robustness of the gut mucosal microbiota is associated with Crohn's disease remission after surgery.

Mondot S, Lepage P, Seksik P, Allez M, Tréton X, Bouhnik Y, Colombel JF, Leclerc M, Pochart P, Doré J, Marteau P; GETAID.

Gut. 2016 Jun;65(6):954-62. doi: 10.1136/gutjnl-2015-309184. Epub 2015 Dec 1.

3.

Microbial diversity observed during hemp retting.

Ribeiro A, Pochart P, Day A, Mennuni S, Bono P, Baret JL, Spadoni JL, Mangin I.

Appl Microbiol Biotechnol. 2015 May;99(10):4471-84. doi: 10.1007/s00253-014-6356-5. Epub 2015 Jan 11.

PMID:
25575888
4.

Long-term changes in human colonic Bifidobacterium populations induced by a 5-day oral amoxicillin-clavulanic acid treatment.

Mangin I, Lévêque C, Magne F, Suau A, Pochart P.

PLoS One. 2012;7(11):e50257. doi: 10.1371/journal.pone.0050257. Epub 2012 Nov 27.

5.

Effect of dietary fibre of barley variety 'Rihane' on azoxymethane-induced aberrant crypt foci development and on colonic microbiota diversity in rats.

Lahouar L, Pochart P, Salem HB, El Felah M, Mokni M, Magne F, Mangin I, Suau A, Pereira E, Hammami M, Achour L.

Br J Nutr. 2012 Dec 14;108(11):2034-42. doi: 10.1017/S0007114512000219. Epub 2012 Mar 14.

PMID:
22414704
6.

High-throughput sequencing of PCR products tagged with universal primers using 454 life sciences systems.

Daigle D, Simen BB, Pochart P.

Curr Protoc Mol Biol. 2011 Oct;Chapter 7:Unit7.5. doi: 10.1002/0471142727.mb0705s96.

PMID:
21987058
7.

Short-chain fatty acids and commensal microbiota in the faeces of severely malnourished children with cholera rehydrated with three different carbohydrates.

Monira S, Hoq MM, Chowdhury AK, Suau A, Magne F, Endtz HP, Alam M, Rahman M, Pochart P, Desjeux JF, Alam NH.

Eur J Clin Nutr. 2010 Oct;64(10):1116-24. doi: 10.1038/ejcn.2010.123. Epub 2010 Aug 4.

PMID:
20683462
8.

Amoxicillin treatment modifies the composition of Bifidobacterium species in infant intestinal microbiota.

Mangin I, Suau A, Gotteland M, Brunser O, Pochart P.

Anaerobe. 2010 Aug;16(4):433-8. doi: 10.1016/j.anaerobe.2010.06.005. Epub 2010 Jun 19.

PMID:
20601031
9.

Metronidazole effects on microbiota and mucus layer thickness in the rat gut.

Pélissier MA, Vasquez N, Balamurugan R, Pereira E, Dossou-Yovo F, Suau A, Pochart P, Magne F.

FEMS Microbiol Ecol. 2010 Sep;73(3):601-10. doi: 10.1111/j.1574-6941.2010.00916.x. Epub 2010 May 25.

10.

Crypt abscess-associated microbiota in inflammatory bowel disease and acute self-limited colitis.

Sokol H, Vasquez N, Hoyeau-Idrissi N, Seksik P, Beaugerie L, Lavergne-Slove A, Pochart P, Marteau P.

World J Gastroenterol. 2010 Feb 7;16(5):583-7.

11.

Molecular analysis of intestinal microbiota of rainbow trout (Oncorhynchus mykiss).

Navarrete P, Magne F, Mardones P, Riveros M, Opazo R, Suau A, Pochart P, Romero J.

FEMS Microbiol Ecol. 2010 Jan;71(1):148-56. doi: 10.1111/j.1574-6941.2009.00769.x.

12.

Time course of bacterial diversity in stool samples of malnourished children with cholera receiving treatment.

Monira S, Alam NH, Suau A, Magne F, Nair GB, Karmakar PC, Rahman M, Pochart P, Desjeux JF.

J Pediatr Gastroenterol Nutr. 2009 May;48(5):571-8. doi: 10.1097/MPG.0b013e3181831867.

PMID:
19252449
13.

Differential effects of Bifidobacterium pseudolongum strain Patronus and metronidazole in the rat gut.

Vasquez N, Suau A, Magne F, Pochart P, Pélissier MA.

Appl Environ Microbiol. 2009 Jan;75(2):381-6. doi: 10.1128/AEM.01731-08. Epub 2008 Nov 21.

14.

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients.

Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G, Grangette C, Vasquez N, Pochart P, Trugnan G, Thomas G, Blottière HM, Doré J, Marteau P, Seksik P, Langella P.

Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16731-6. doi: 10.1073/pnas.0804812105. Epub 2008 Oct 20.

15.

A phase I study of CR002, a fully-human monoclonal antibody against platelet-derived growth factor-D.

Hawthorne T, Giot L, Blake L, Kuang B, Gerwien R, Smithson G, Hahne W, Mansfield T, Starling GC, Pochart P, Hoelscher D, Halvorsen YD.

Int J Clin Pharmacol Ther. 2008 May;46(5):236-44.

PMID:
18538109
16.

Effects on faecal microbiota of dietary and acidic oligosaccharides in children during partial formula feeding.

Magne F, Hachelaf W, Suau A, Boudraa G, Bouziane-Nedjadi K, Rigottier-Gois L, Touhami M, Desjeux JF, Pochart P.

J Pediatr Gastroenterol Nutr. 2008 May;46(5):580-8. doi: 10.1097/MPG.0b013e318164d920.

PMID:
18493215
17.

Patchy distribution of mucosal lesions in ileal Crohn's disease is not linked to differences in the dominant mucosa-associated bacteria: a study using fluorescence in situ hybridization and temporal temperature gradient gel electrophoresis.

Vasquez N, Mangin I, Lepage P, Seksik P, Duong JP, Blum S, Schiffrin E, Suau A, Allez M, Vernier G, Tréton X, Doré J, Marteau P, Pochart P.

Inflamm Bowel Dis. 2007 Jun;13(6):684-92.

PMID:
17206669
18.

Antioxidant effects of metronidazole in colonic tissue.

Pélissier MA, Marteau P, Pochart P.

Dig Dis Sci. 2007 Jan;52(1):40-4. Epub 2006 Dec 7.

PMID:
17151808
19.

A longitudinal study of infant faecal microbiota during weaning.

Magne F, Hachelaf W, Suau A, Boudraa G, Mangin I, Touhami M, Bouziane-Nedjadi K, Pochart P.

FEMS Microbiol Ecol. 2006 Dec;58(3):563-71.

20.

Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease.

Seksik P, Sokol H, Lepage P, Vasquez N, Manichanh C, Mangin I, Pochart P, Doré J, Marteau P.

Aliment Pharmacol Ther. 2006 Oct;24 Suppl 3:11-8. Review.

22.

Characterization of human intestinal bifidobacteria using competitive PCR and PCR-TTGE.

Mangin I, Suau A, Magne F, Garrido D, Gotteland M, Neut C, Pochart P.

FEMS Microbiol Ecol. 2006 Jan;55(1):28-37.

23.

Fecal microbial community in preterm infants.

Magne F, Suau A, Pochart P, Desjeux JF.

J Pediatr Gastroenterol Nutr. 2005 Oct;41(4):386-92. Review. No abstract available.

PMID:
16205503
24.

Modulation of the fecal microbiota by the intake of a Lactobacillus johnsonii La1-containing product in human volunteers.

Garrido D, Suau A, Pochart P, Cruchet S, Gotteland M.

FEMS Microbiol Lett. 2005 Jul 15;248(2):249-56.

25.

Review article: gut flora and inflammatory bowel disease.

Marteau P, Lepage P, Mangin I, Suau A, Doré J, Pochart P, Seksik P.

Aliment Pharmacol Ther. 2004 Oct;20 Suppl 4:18-23. Review.

26.

Immunoproliferative small intestinal disease associated with Campylobacter jejuni.

Lecuit M, Abachin E, Martin A, Poyart C, Pochart P, Suarez F, Bengoufa D, Feuillard J, Lavergne A, Gordon JI, Berche P, Guillevin L, Lortholary O.

N Engl J Med. 2004 Jan 15;350(3):239-48.

27.

A protein interaction map of Drosophila melanogaster.

Giot L, Bader JS, Brouwer C, Chaudhuri A, Kuang B, Li Y, Hao YL, Ooi CE, Godwin B, Vitols E, Vijayadamodar G, Pochart P, Machineni H, Welsh M, Kong Y, Zerhusen B, Malcolm R, Varrone Z, Collis A, Minto M, Burgess S, McDaniel L, Stimpson E, Spriggs F, Williams J, Neurath K, Ioime N, Agee M, Voss E, Furtak K, Renzulli R, Aanensen N, Carrolla S, Bickelhaupt E, Lazovatsky Y, DaSilva A, Zhong J, Stanyon CA, Finley RL Jr, White KP, Braverman M, Jarvie T, Gold S, Leach M, Knight J, Shimkets RA, McKenna MP, Chant J, Rothberg JM.

Science. 2003 Dec 5;302(5651):1727-36. Epub 2003 Nov 6.

28.

Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon.

Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, Marteau P, Jian R, Doré J.

Gut. 2003 Feb;52(2):237-42.

29.

Comparative study of bacterial groups within the human cecal and fecal microbiota.

Marteau P, Pochart P, Doré J, Béra-Maillet C, Bernalier A, Corthier G.

Appl Environ Microbiol. 2001 Oct;67(10):4939-42.

31.

Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization.

Sghir A, Gramet G, Suau A, Rochet V, Pochart P, Dore J.

Appl Environ Microbiol. 2000 May;66(5):2263-6.

32.

A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae.

Uetz P, Giot L, Cagney G, Mansfield TA, Judson RS, Knight JR, Lockshon D, Narayan V, Srinivasan M, Pochart P, Qureshi-Emili A, Li Y, Godwin B, Conover D, Kalbfleisch T, Vijayadamodar G, Yang M, Johnston M, Fields S, Rothberg JM.

Nature. 2000 Feb 10;403(6770):623-7.

PMID:
10688190
33.

Intestinal barrier function and cow's milk sensitization in guinea pigs fed milk or fermented milk.

Terpend K, Blaton MA, Candalh C, Wal JM, Pochart P, Heyman M.

J Pediatr Gastroenterol Nutr. 1999 Feb;28(2):191-8.

PMID:
9932854
34.

Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans.

Bouhnik Y, Vahedi K, Achour L, Attar A, Salfati J, Pochart P, Marteau P, Flourié B, Bornet F, Rambaud JC.

J Nutr. 1999 Jan;129(1):113-6.

PMID:
9915885
35.

Design and evaluation of a 16S rRNA-targeted oligonucleotide probe for specific detection and quantitation of human faecal Bacteroides populations.

Doré J, Sghir A, Hannequart-Gramet G, Corthier G, Pochart P.

Syst Appl Microbiol. 1998 Mar;21(1):65-71.

PMID:
9741111
36.

Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect?

Briet F, Pochart P, Marteau P, Flourie B, Arrigoni E, Rambaud JC.

Gut. 1997 Nov;41(5):632-5.

37.

Conserved properties between functionally distinct MutS homologs in yeast.

Pochart P, Woltering D, Hollingsworth NM.

J Biol Chem. 1997 Nov 28;272(48):30345-9.

38.

Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans.

Bouhnik Y, Flourié B, D'Agay-Abensour L, Pochart P, Gramet G, Durand M, Rambaud JC.

J Nutr. 1997 Mar;127(3):444-8.

PMID:
9082028
39.
41.

A three-hybrid system to detect RNA-protein interactions in vivo.

SenGupta DJ, Zhang B, Kraemer B, Pochart P, Fields S, Wickens M.

Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8496-501.

42.

Diversity of H2/CO2-utilizing acetogenic bacteria from feces of non-methane-producing humans.

Bernalier A, Rochet V, Leclerc M, Doré J, Pochart P.

Curr Microbiol. 1996 Aug;33(2):94-9.

PMID:
8662179
43.

Most probable number enumeration of H2-utilizing acetogenic bacteria from the digestive tract of animals and man.

Doré J, Morvan B, Rieu-Lesme F, Goderel I, Gouet P, Pochart P.

FEMS Microbiol Lett. 1995 Jul 15;130(1):7-12.

PMID:
7557299
44.

Tolerance and absorption of lactose from milk and yogurt during short-bowel syndrome in humans.

Arrigoni E, Marteau P, Briet F, Pochart P, Rambaud JC, Messing B.

Am J Clin Nutr. 1994 Dec;60(6):926-9.

PMID:
7985635
45.

Pyxigraphic sampling to enumerate methanogens and anaerobes in the right colon of healthy humans.

Pochart P, Lémann F, Flourié B, Pellier P, Goderel I, Rambaud JC.

Gastroenterology. 1993 Nov;105(5):1281-5.

PMID:
8224632
46.

Manipulation of the human gut microflora.

Rambaud JC, Bouhnik Y, Marteau P, Pochart P.

Proc Nutr Soc. 1993 Aug;52(2):357-66. Review. No abstract available.

PMID:
8234357
48.
49.

The fate and effects of transiting, nonpathogenic microorganisms in the human intestine.

Marteau P, Pochart P, Bouhnik Y, Rambaud JC.

World Rev Nutr Diet. 1993;74:1-21. Review. No abstract available.

PMID:
8212727
50.

Interrelations between populations of methanogenic archaea and sulfate-reducing bacteria in the human colon.

Pochart P, Doré J, Lémann F, Goderel I, Rambaud JC.

FEMS Microbiol Lett. 1992 Nov 1;77(1-3):225-8.

PMID:
1459413

Supplemental Content

Loading ...
Support Center